Investing Profile

Kenneth Grisé

InvestorVC
Principal, Healthcare Investments at Sixty Degree Capital
sixtydegreecapital.comToronto, Ontario
Photo of Kenneth Grisé, Principal at Sixty Degree Capital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
University of Toronto Network
36 CONNECTIONS
$100K - $5.0M
$1.5M
Board Observer BOLD Longevity Growth Fund2025 - Present
Principal, Healthcare Investments Sixty Degree Capital2024 - Present
Scientific Consultant Ken Grisé Science Consulting2013 - Present
Associate, Healthcare Investments Sixty Degree Capital2021 - 2024
Investor Parabilis Medicines2024 - 2024
Investor Strive Health2023 - 2023
Investor NextPoint Therapeutics, Inc.2023 - 2023
Scientific Consultant Vivid Foundry Corp.2019 - 2023
Investor Everside Health2022 - 2022
Investor RefleXion Medical2022 - 2022
Investor Korro Bio, Inc.2022 - 2022
Investor TransThera | 药捷安康2021 - 2021
Investor Turnstone Biologics2021 - 2021
Investor Bionaut Labs2021 - 2021
Investor T-knife Therapeutics2021 - 2021
Scientist - Academic-Industry Partnership Endogena Therapeutics, Inc.2016 - 2020
Teaching Assistant University of Toronto2013 - 2018
Head Teaching Assistant - General and Human Genetics (HMB265) University of Toronto2016 - 2017
Guest Lecturer University of Toronto2015 - 2016
Scientific Consultant Ubisoft2015 - 2016
Scientific Consultant CCRM2013 - 2014
Teaching Assistant Western University2010 - 2012
Research Assistant / Work-Study Student Western University2009 - 2010
Intern / Research Assistant Sernova Corp.2007 - 2008
University of Toronto Doctor of Philosophy (Ph.D.) Molecular Genetics / Stem Cells / Neurobiology
Western University Master of Science (M.Sc.) Kinesiology/Integrative Physiology
Western University Honours BSc Physiology and Psychology, Double Major